MCR American Pharmaceuticals

MCR American Pharmaceuticals was a specialty pharmaceutical company based in West Bloomfield, Michigan, that focused on the respiratory and allergy markets. The company developed and distributed a range of prescription cough and cold medications, most notably combination therapies like MCR-HC, MCR-DM, and MCR-D. These products typically combined antitussives, antihistamines, or decongestants to treat symptoms of the common cold and allergic rhinitis. However, many of the company's offerings were marketed as unapproved prescription drugs, which became the subject of FDA regulatory actions in the early 2010s. As a result of these enforcement initiatives, the company's core products were discontinued or removed from the market, and the company was officially dissolved in 2013.